¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Citrate of Magnesia Solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ophthalmic solution
    ¾È°ú¿ë¾×
  • physiological salt solution
    »ý¸®½Ä¿°¼ö
  • perfect solution
    ÀÌ»ó¿ë¾×, ¿ÏÀü¿ë¾×
  • regular solution
    Á¤±Ô¿ë¾×
  • Ringer¡¯s lactate solution
    ¸µ°ÅÁ¥»ê¿ë¾×
  • Ringer¡¯s solution
    ¸µ°Å¿ë¾×
  • solution
    1. ¿ë¾×, ¾× 2. Ç®ÀÌ, ÇØ¹ý
  • saturated solution
    Æ÷È­¿ë¾×
  • standard solution
    Ç¥ÁØ¿ë¾×
  • stock solution
    ¿ø¾×
  • stop solution
    Á¤Áö¾×
  • supersaturated solution
    °úÆ÷È­¾×
  • sclerosing solution
    °æÈ­¾×
  • seminormal solution
    ¹Ý±ÔÁ¤¾×
  • saline solution
    ½Ä¿°¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • isotonic solution
    µîÀå¾×
  • low-ionic-strength salt solution
    ÀúÀ̿°­µµ¿°¿ë¾×
  • maintenance solution
    À¯Áö¿ë¾×
  • molar solution
    ¸ô¾×
  • nitromersol solution
    ´ÏÆ®·Î¸Þ¸£¼Ö¿ë¾×
  • normal oxidizing solution
    ±ÔÁ¤»êÈ­¾×
  • normal saline solution
    (¢¡physiological salt) »ý¸®½Ä¿°¼ö
  • ophthalmic solution
    ¾È°ú¿ë¾×Á¦
  • percentage solution
    ¹éºÐÀ²¿ë¾×
  • perfect solution
    ÀÌ»ó¿ë¾×
  • physiological salt solution
    »ý¸®½Ä¿°¼ö
  • regular solution
    Á¤±Ô¿ë¾×
  • solution
    ¿ë¾×
  • saturated solution
    Æ÷È­¿ë¾×
  • sclerosing solution
    °æÈ­¾×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö(î¸íåãÝç¤â©).
  • hypotonic solution
    ÀúÀ强¿ë¾×(î¸íåàõéÁäû).
  • physiologic solution
    »ý¸®¿ë¾×
  • physiological salt solution
    »ý¸®½Ä¿°¼ö
  • physiological solution
    »ý¸®¿ë¾×(ßæìµéÁäû).
  • regular solution
    Á¤±Ô¿ë¾×(ïáЮéÁäû).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • buffer solution
    ¿ÏÃæ¾×(èÐõúäû)
  • buffering solution
    ¿ÏÃæ¾×.
  • cardioplegic solution
    ½ÉÁ¤Áö¿ë¾×(ãýïÎò­éÂäû)
  • cardioplegic solution
    ½ÉÁ¤Áö¿ë¾×.
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×(¡­éÁäû), ±³Áú¿ë¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×(¡­éÁäû).
  • conjugate solution
    ¦¿ë¾×(¡­éÁäû).
  • crystalloid solution
    Á¤Áú¾×.
  • crystalloid solution
    Á¤Áú¾×
  • culture solution
    ¹è¾ç¾×.
  • decontaminating solution
    Å»¿À¿°¿ë¾×
  • diluted ammonia solution<³ª> liquor ammon iae dulutus
    ¹±Àº ¾Ï¸ð´Ï¾Æ¼ö.
  • disclosing solution
    Ä¡ÅÂÂø»ö¾×(¡­ó·ßääû).
  • equimolecular solution
    µîºÐÀÚ¿ë¾×.
  • etching solution
    ºÎ½Ä(ݯãÚ)¿ë¾×.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • osmolar solution
    ¿À½º¸ô¶ó¸£ ¿ë¾×(éÁäû)
  • percent solution
    ÆÛ¼¾Æ® ¿ë¾×(éÁäû)
  • saturated solution
    Æ÷È­ ¿ë¾×(øéûùéÁäû)
  • solution
    ¿ë¾×(éÁäû)
  • solution hybridization
    ¿ë¾×(éÁäû) Æ¢±âÇü¼º(û¡à÷)
  • standard solution
    Ç¥ÁØ¿ë¾×(øöñÞéÁäû)
  • supersaturated solution
    °úÆ÷È­ ¿ë¾× (ΦøéûúéÁäû)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TCBS Thiosulfate Citrate Bile salt Sucrose agar
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
CIT citrate; combined intermittent therapy; conjugated-immunoglobulin technique; crossed intrinsic trans...
cit citrate
CPD calcium pyrophosphate deposition; cephalopelvic disproportion; cerebelloparenchymal disorder; childh...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
OTFC Oral transmucosal fentanyl citrate
RBC Ranitidine bismuth citrate
ATBC acetyl N-tributyl citrate
CS citrate synthetase
DEC-C diethylcarbamazine citrate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lactated Ringer's solution
    À¯»êÀ» °¡ÇÑ ¸µ°Å ¾×
  • Naegeli's solution
    ³×°Ö¸® ¿ë¾×
    È¿¸ð, °õÆÎÀÌ µî¿¡ »ç¿ëÇÏ´Â Àΰø ¹èÁö·Î, ÀÌ¿°±â¼º Àλê Ä®·ý 0.2g, ¿°È­ Ä®½· 0.1g, ÁÖ¼®»ê ¾Ï¸ð´½ 10gÀ» ¹° 1,000cc¿¡ ³ìÀÎ °Í.
  • normal saline solution
    Á¤¼º »ý¸® ½Ä¿°¼ö
  • novocaine solution
    ³ëº¸ÄÉÀÎ ¿ë¾×
  • ophthalmic solution
    ¾È°ú¿ë ¾×Á¦
  • parenteral solution
    ÁÖ»ç¾×
  • povidone-iodine solution

    powder (ºÐ¸», »êÁ¦

    °íÇüÀÇ ¾à¹°À» °¥°Å³ª ºÎ½¤ ¾òÀº ¼Ò¸³ÀÚÀÇ ÁýÇÕü.
  • ringer's lactate solution
    ¸µ°Å¾×
    tri
  • Ringer's solution
    ¸µ°Å ¾×
  • solid solution
    °í¿ëü
    1. °íü »óÅ¿¡¼­ ¿ë¸Å ¿øÀÚ¿Í ¿ëÁú ¿øÀÚ°¡ ¼­·Î ³ì¾Æ ÀÖ´Â ÇÕ±Ý. 2. ¹°¿¡ ½Ä¿°À» ¼¯¾î¼­ ´ÜÀÏ»óÀÇ ¿ë¾×À» ¸¸µå´Â °Í°ú °°ÀÌ, °íü »óÅ¿¡¼­µµ ÇÑ ±Ý¼Ó¿¡ ´Ù¸¥ ±Ý¼Ó ¶Ç´Â ºñ±Ý¼ÓÀÌ ¼¯¿© µé¾î°¡ ´ÜÀÏ»óÀÇ °íü »óÅÂÀÇ ¿ë¾×À» ¸¸µå´Â °æ¿ì°¡ Àִµ¥ À̰ÍÀÌ °í¿ëüÀÌ´Ù.
  • solution tablet
    ¿ëÇØÁ¤
  • stock solution
    ¿ø¾×
  • strong ammonia solution
    °­ ¾Ï¸ð´Ï¾Æ¼ö
    ¹«»ö Åõ¸íÇÑ °­ ¾ËÄ®¸®¼º ¿ë¾×. 27¡­30%ÀÇ ¾Ï¸ð´Ï¾Æ¸¦ ÇÔÀ¯ÇÑ´Ù. ¿ë¸Å ¹× ¾Ï¸ð´Ï¾Æ¿øÀ¸·Î »ç¿ëµÈ´Ù.
  • supersaturated solution
    °úÆ÷È­ ¾×
    ¿µ±¸È÷ ÇÔÀ¯µÉ ¼ö ÀÖ´Â ¾ç ÀÌ»óÀÇ ¿ëÁúÀÌ ³ì¾Æ ÀÖ´Â ºÒ¾ÈÁ¤ÇÑ ¿ë¾×.
  • thymol solution
    Ƽ¸ô ¿ë¾×
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
copper citrate A salt of copper used as an astringent and antiseptic.
Synonym: copper citrate.
(05 Mar 2000)
potassium citrate <chemical> A systemic alkaliser, electrolyte replenisher, diuretic, and expectorant, usually administered orally. It is sometimes used in veterinary medicine as a nonirritating diuretic.
Pharmacological action: diuretics, expectorants.
(12 Dec 1998)
cupric citrate A salt of copper used as an astringent and antiseptic.
Synonym: copper citrate.
(05 Mar 2000)
Simmons' citrate medium A diagnostic medium used in the differentiation of species of Enterobacteriaceae, based on their ability to utilise sodium citrate as the sole source of carbon.
(05 Mar 2000)
sodium acid citrate Na3C6H5O7 -2H2O; trisodium citrate;used as diuretic, antilithic, systemic and urinary alkaliser, expectorant, and anticoagulant (in vitro).
Synonym: sodium acid citrate.
(05 Mar 2000)
sodium citrate Na3C6H5O7 -2H2O; trisodium citrate;used as diuretic, antilithic, systemic and urinary alkaliser, expectorant, and anticoagulant (in vitro).
Synonym: sodium acid citrate.
(05 Mar 2000)
sodium citrate acid C6H6O7Na-11/2H2O; disodium hydrogen citrate;same actions and uses as sodium citrate; in addition, it may be used in solutions of glucose without producing caramelization of the latter during autoclaving.
(05 Mar 2000)
sufentanil citrate N-[4-(Methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-p iperidyl]proprionanilide;an injectable narcotic with short duration of effect resembling fentanil; used in "balanced anaesthesia".
(05 Mar 2000)
deptropine citrate 3a-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy]1aH,5aH-tropane citrate;an antihistaminic agent with anticholinergic properties.
Synonym: dibenzheptropine citrate.
(05 Mar 2000)
dibenzheptropine citrate 3a-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy]1aH,5aH-tropane citrate;an antihistaminic agent with anticholinergic properties.
Synonym: dibenzheptropine citrate.
(05 Mar 2000)
diethylcarbamazine citrate N,N-Diethyl-4-methyl-1-piperazinecarboxamide citrate;an effective microfilaricide, although relatively ineffective against the adult filariae.
(05 Mar 2000)
orphenadrine citrate An antihistaminic that also has the same action and use as orphenadrine hydrochloride.
(05 Mar 2000)
tamoxifen citrate (Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine citrate (1:1);an anti-oestrogen agent used in the treatment of breast cancer.
(05 Mar 2000)
effervescent lithium citrate A preparation containing lithium citrate, sodium bicarbonate, tartaric acid, and citric acid; same use as potassium or sodium citrate.
(05 Mar 2000)
effervescent magnesium citrate Magnesium carbonate, citric acid, sodium bicarbonate, and sugar, moistened with alcohol, passed through a sieve, and dried to a coarse granular powder; used as a laxative.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á